AECOM to provide enhanced support to clients in response to U.S. EPA’s latest PFAS regulatory compliance requirements
With now over 1,200 successful PFAS projects at more than 600 locations globally, the Company is advising clients through its industry-leading emerging contaminants... Read more.
Fastenal Company Reports 2024 First Quarter Earnings
WINONA, Minn.–(BUSINESS WIRE)–Fastenal Company (Nasdaq:FAST), a leader in the wholesale distribution of industrial and construction supplies, today announced... Read more.
Wallbox Announces Timing of its First Quarter 2024 Financial Results
BARCELONA, Spain–(BUSINESS WIRE)–Wallbox (NYSE: WBX), a leading provider of electric vehicle (EV) charging and energy management solutions worldwide,... Read more.
NuScale Power to Hold First Quarter 2024 Earnings Conference Call on May 9, 2024
PORTLAND, Ore.–(BUSINESS WIRE)–NuScale Power Corporation (NYSE: SMR), the industry-leading provider of proprietary and innovative advanced small modular... Read more.
CarMax Reports Fourth Quarter and Fiscal Year 2024 Results
RICHMOND, Va.–(BUSINESS WIRE)–CarMax, Inc. (NYSE:KMX) today reported results for the fourth quarter and fiscal year ended February 29, 2024. Fourth Quarter... Read more.
Kontoor Brands Announces First Quarter 2024 Earnings and Conference Call Date
GREENSBORO, N.C.–(BUSINESS WIRE)–$KTB–Kontoor Brands, Inc. (NYSE: KTB), a global lifestyle apparel company, with a portfolio led by two of the... Read more.
Global Blue Releases the Monthly Tax Free Shopping Business Update for March 2024
Fresh data from Global Blue reveals that the global dynamic recovery for Tax Free Shopping remains strong across Continental Europe and continues to accelerate across... Read more.
Henry Schein to Webcast First Quarter 2024 Conference Call on Tuesday, May 7, 2024 at 10:00 A.M. ET
MELVILLE, N.Y.–(BUSINESS WIRE)–Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and... Read more.
Sage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain... Read more.
Giesecke+Devrient Sets New Highs and Generates Revenues of Three Billion Euros for the First Time
MUNICH–(BUSINESS WIRE)–Giesecke+Devrient (G+D) achieved the strongest growth in its history in fiscal year 2023, setting new records for sales, sales... Read more.